Catalyst Wire Dossier Catalyst Wire Dossier

MEDI-560

· MedImmune LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEDI-560, covering 2011-12-30 to 2011-12-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age [Phase 1, Phase 2]

See pricing